Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy
Clinical trial NCT00589420 · COMPLETED
Trial details
- NCT number
- NCT00589420
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-27
- Primary completion
- 2010-02-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.